Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity

Journal of Experimental Medicine

Volumn 207, Issue 12, 2010, Pages 2609-2619

  Weber, Felix C ^a,b   Esser, Philipp R ^a,b   Müller, Tobias ^a   Ganesan, Jayanthi ^a,b   Pellegatti, Patrizia ^c   Simon, Markus M ^d   Zeiser, Robert ^a   Idzko, Marco ^a   Jakob, Thilo ^a   Martin, Stefan F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF FERRARA   (Italy)

^d MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; ADENOSINE TRIPHOSPHATE; ALLERGEN; APYRASE; CRYOPYRIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PURINERGIC P2X7 RECEPTOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME RELEASE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; WILD TYPE;

ADENOSINE TRIPHOSPHATE; ALUM COMPOUNDS; ANIMALS; DERMATITIS, CONTACT; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; RECEPTORS, PURINERGIC P2X7; TRINITROBENZENESULFONIC ACID;

EID: 78649414124     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20092489     Document Type: Article

References (59)

1. Abbracchio, M.P., G. Burnstock, J.M. Boeynaems, E.A. Barnard, J.L. Boyer, C. Kennedy, G.E. Knight, M. Fumagalli, C. Gachet, K.A. Jacobson, and G.A. Weisman. 2006. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58:281-341. doi:10.1124/pr.58.3.3
2. Ade, N., F. Leon, M. Pallardy, J.L. Peiffer, S. Kerdine-Romer, M.H. Tissier, P.A. Bonnet, I. Fabre, and J.C. Ourlin. 2009. HMOX1 and NQO1 genes are upregulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway. Toxicol. Sci. 107:451-460. doi:10.1093/toxsci/kfn243
3. Antonopoulos, C., M. Cumberbatch, R.J. Dearman, R.J. Daniel, I. Kimber, and R.W. Groves. 2001. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol. 166:3672-3677. (Pubitemid 32224888)
4. Antonopoulos, C., M. Cumberbatch, J.B. Mee, R.J. Dearman, X.Q. Wei, F.Y. Liew, I. Kimber, and R.W. Groves. 2008. IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis. J. Leukoc. Biol. 83:361-367. doi:10.1189/jlb.0604352
5. Baraldi, P.G., F. Di Virgilio, and R. Romagnoli. 2004. Agonists and antagonists acting at P2X7 receptor. Curr. Top. Med. Chem. 4:1707-1717. doi:10.2174/1568026043387223
6. Burnstock, G. 2008. Purinergic signalling and disorders of the central nervous system. Nat. Rev. Drug Discov. 7:575-590. doi:10.1038/nrd2605
7. Cumberbatch, M., R.J. Dearman, C. Antonopoulos, R.W. Groves, and I. Kimber. 2001. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism. Immunology. 102:323-330. doi:10.1046/j.13652567.2001.01187.x
8. Di Virgilio, F. 2007. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol. Sci. 28:465-472. doi:10.1016/j.tips.2007.07.002
9. Dinarello, C.A. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27:519-550. doi:10.1146/annurev. immunol.021908.132612
10. Dudda, J.C., and S.F. Martin. 2004. Tissue targeting of T cells by DCs and microenvironments. Trends Immunol. 25:417-421. doi:10.1016/j.it.2004.05.008
11. Edele, F., P.R. Esser, C. Lass, M.N. Laszczyk, E. Oswald, C.M. Strüh, A. Rensing-Ehl, and S.F. Martin. 2007. Innate and adaptive immune responses in allergic contact dermatitis and autoimmune skin diseases. Inflamm. Allergy Drug Targets. 6:236-244. doi:10.2174/187152807783334292
12. Edinger, M., Y.A. Cao, M.R. Verneris, M.H. Bachmann, C.H. Contag, and R.S. Negrin. 2003. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood. 101:640-648. doi:10.1182/blood2002061751
13. Eisenbarth, S.C., O.R. Colegio, W. O'Connor, F.S. Sutterwala, and R.A. Flavell. 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 453:1122-1126. doi:10.1038/ nature06939
14. Enk, A.H., and S.I. Katz. 1992. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA. 89:1398-1402. doi:10.1073/pnas.89.4.1398
15. Ferrari, D., P. Chiozzi, S. Falzoni, M. Dal Susino, L. Melchiorri, O.R. Baricordi, and F. Di Virgilio. 1997. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159:1451-1458.
16. Ferrari, D., C. Pizzirani, E. Adinolfi, R.M. Lemoli, A. Curti, M. Idzko, E. Panther, and F. Di Virgilio. 2006. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176:3877-3883. (Pubitemid 44264361)
17. Franchi, L., and G. Núñez. 2008. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38:2085-2089. doi:10.1002/eji.200838549
18. Freudenberg, M.A., P.R. Esser, T. Jakob, C. Galanos, and S.F. Martin. 2009. Innate and adaptive immune responses in contact dermatitis: analogy with infections. G. Ital. Dermatol. Venereol. 144:173-185.
19. Gabay, C., C. Lamacchia, and G. Palmer. 2010. IL-1 pathways in inflammation and human diseases. Nat. Rev. Rheumatol. 6:232-241. doi:10.1038/nrrheum.2010.4
20. Ghiringhelli, F., L. Apetoh, A. Tesniere, L. Aymeric, Y. Ma, C. Ortiz, K. Vermaelen, T. Panaretakis, G. Mignot, E. Ullrich, et al. 2009. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 15:1170-1178. doi:10.1038/nm.2028
21. Granstein, R.D., W. Ding, J. Huang, A. Holzer, R.L. Gallo, A. Di Nardo, and J.A. Wagner. 2005. Augmentation of cutaneous immune responses by ATP gamma S: purinergic agonists define a novel class of immunologic adjuvants. J. Immunol. 174:7725-7731.
22. Idzko, M., H. Hammad, M. van Nimwegen, M. Kool, M.A. Willart, F. Muskens, H.C. Hoogsteden, W. Luttmann, D. Ferrari, F. Di Virgilio, et al. 2007. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13:913-919. doi:10.1038/nm1617
23. Jiang, D., J. Liang, Y. Li, and P.W. Noble. 2006. The role of Toll-like receptors in non-infectious lung injury. Cell Res. 16:693-701. doi:10.1038/sj.cr.7310085
24. Kawai, T., and S. Akira. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21:317-337. doi:10.1093/intimm/dxp017
25. Kim, H.J., B. Barajas, M. Wang, and A.E. Nel. 2008. Nrf2 activation by sulforaphane restores the age-related decrease of T(H)1 immunity: role of dendritic cells. J. Allergy Clin. Immunol. 121:1255-1261: e7. doi:10.1016/j.jaci.2008.01.016
26. Klekotka, P.A., L. Yang, and W.M. Yokoyama. 2010. Contrasting roles of the IL-1 and IL-18 receptors in MyD88-dependent contact hypersensitivity. J. Invest. Dermatol. 130:184-191. doi:10.1038/jid.2009.242
27. Kool, M., V. Pétrilli, T. De Smedt, A. Rolaz, H. Hammad, M. van Nimwegen, I.M. Bergen, R. Castillo, B.N. Lambrecht, and J. Tschopp. 2008. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181:3755-3759.
28. Labow, M., D. Shuster, M. Zetterstrom, P. Nunes, R. Terry, E.B. Cullinan, T. Bartfai, C. Solorzano, L.L. Moldawer, R. Chizzonite, and K.W. McIntyre. 1997. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159:2452-2461.
29. Lass, C., I. Merfort, and S.F. Martin. 2010. In vitro and in vivo analysis of pro- and anti-inflammatory effects of weak and strong contact allergens. Exp. Dermatol. doi:10.1111/j.16000625.2010.01136.x
30. Lazarowski, E.R., R.C. Boucher, and T.K. Harden. 2003. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol. Pharmacol. 64:785-795. doi:10.1124/mol.64.4.785
31. Li, H., S.B. Willingham, J.P. Ting, and F. Re. 2008. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181:17-21.
32. Mariathasan, S., D.S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W.P. Lee, Y. Weinrauch, D.M. Monack, and V.M. Dixit. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 440:228-232. doi:10.1038/nature04515
33. Martin, S.F., and T. Jakob. 2008. From innate to adaptive immune responses in contact hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 8:289-293. doi:10.1097/ACI.0b013e3283088cf9
34. Martin, S.F., J.C. Dudda, E. Bachtanian, A. Lembo, S. Liller, C. Dürr, M.M. Heimesaat, S. Bereswill, G. Fejer, R. Vassileva, et al. 2008. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J. Exp. Med. 205:2151-2162. doi:10.1084/jem.20070509
35. Martinon, F., V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 440:237-241. doi:10.1038/nature04516
36. Martinon, F., A. Mayor, and J. Tschopp. 2009. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27:229-265. doi:10.1146/annurev. immunol.021908.132715
37. Matsue, H., D. Edelbaum, D. Shalhevet, N. Mizumoto, C. Yang, M.E. Mummert, J. Oeda, H. Masayasu, and A. Takashima. 2003. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J. Immunol. 171:3010-3018. (Pubitemid 37093524)
38. Matsushima, H., Y. Ogawa, T. Miyazaki, H. Tanaka, A. Nishibu, and A. Takashima. 2010. Intravital imaging of IL-1beta production in skin. J. Invest. Dermatol. 130:1571-1580. doi:10.1038/jid.2010.11
39. Metkar, S.S., C. Menaa, J. Pardo, B. Wang, R. Wallich, M. Freudenberg, S. Kim, S.M. Raja, L. Shi, M.M. Simon, and C.J. Froelich. 2008. Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity. 29:720-733. doi:10.1016/j.immuni.2008.08.014
40. Mizumoto, N., T. Kumamoto, S.C. Robson, J. Sévigny, H. Matsue, K. Enjyoji, and A. Takashima. 2002. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat. Med. 8:358-365. doi:10.1038/nm0402358
41. Mutini, C., S. Falzoni, D. Ferrari, P. Chiozzi, A. Morelli, O.R. Baricordi, G. Collo, P. Ricciardi-Castagnoli, and F. Di Virgilio. 1999. Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J. Immunol. 163:1958-1965.
42. Natsch, A., and R. Emter. 2008. Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals. Toxicol. Sci. 102:110-119. doi:10.1093/toxsci/kfm259
43. North, R.A., and A. Surprenant. 2000. Pharmacology of cloned P2X receptors. Annu. Rev. Pharmacol. Toxicol. 40:563-580. doi:10.1146/annurev. pharmtox.40.1.563
44. Palm, N.W., and R. Medzhitov. 2009. Pattern recognition receptors and control of adaptive immunity. Immunol. Rev. 227:221-233. doi:10.1111/j.1600065X. 2008.00731.x
45. Pellegatti, P., L. Raffaghello, G. Bianchi, F. Piccardi, V. Pistoia, and F. Di Virgilio. 2008. Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One. 3:e2599. doi:10.1371/journal.pone.0002599
46. Ring, S., S.J. Oliver, B.N. Cronstein, A.H. Enk, and K. Mahnke. 2009. CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism. J. Allergy Clin. Immunol. 123:1287-1296: e2. doi:10.1016/j.jaci.2009.03.022
47. Ring, S., A.H. Enk, and K. Mahnke. 2010. ATP activates regulatory T Cells in vivo during contact hypersensitivity reactions. J. Immunol. 184:3408-3416. doi:10.4049/jimmunol.0901751
48. Robson, S.C., E. Kaczmarek, J.B. Siegel, D. Candinas, K. Koziak, M. Millan, W.W. Hancock, and F.H. Bach. 1997. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J. Exp. Med. 185:153-163. doi:10.1084/jem.185.1.153
49. Schmidt, M., B. Raghavan, V. Müller, T. Vogl, G. Fejer, S. Tchaptchet, S. Keck, C. Kalis, P.J. Nielsen, C. Galanos, et al. 2010. Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat. Immunol. 11:814-819. doi:10.1038/ni.1919
50. Seong, S.Y., and P. Matzinger. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4:469-478. doi:10.1038/nri1372
51. Shornick, L.P., P. De Togni, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R.W. Karr, T.A. Ferguson, and D.D. Chaplin. 1996. Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone. J. Exp. Med. 183:1427-1436. doi:10.1084/jem.183.4.1427
52. Sigmundsdottir, H., and E.C. Butcher. 2008. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat. Immunol. 9:981-987. doi:10.1038/ni.f.208
53. So, A., T. De Smedt, S. Revaz, and J. Tschopp. 2007. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res. Ther. 9:R28. doi:10.1186/ar2143
54. Solle, M., J. Labasi, D.G. Perregaux, E. Stam, N. Petrushova, B.H. Koller, R.J. Griffiths, and C.A. Gabel. 2001. Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 276:125-132. doi:10.1074/jbc. M006781200 (Pubitemid 32050297)
55. Surprenant, A., and R.A. North. 2009. Signaling at purinergic P2X receptors. Annu. Rev. Physiol. 71:333-359. doi:10.1146/annurev.physiol.70. 113006.100630
56. Sutterwala, F.S., Y. Ogura, M. Szczepanik, M. Lara-Tejero, G.S. Lichtenberger, E.P. Grant, J. Bertin, A.J. Coyle, J.E. Galán, P.W. Askenase, and R.A. Flavell. 2006. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity. 24:317-327. doi:10.1016/j.immuni.2006.02.004
57. Tsan, M.F., and B. Gao. 2004. Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76:514-519. doi:10.1189/jlb.0304127
58. Watanabe, H., O. Gaide, V. Pétrilli, F. Martinon, E. Contassot, S. Roques, J.A. Kummer, J. Tschopp, and L.E. French. 2007. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 127:1956-1963. doi:10.1038/sj.jid.5700819
59. Wei, X.Q., B.P. Leung, W. Niedbala, D. Piedrafita, G.J. Feng, M. Sweet, L. Dobbie, A.J. Smith, and F.Y. Liew. 1999. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J. Immunol. 163:2821-2828.